AstraZeneca collaborates with Cambridge Medical Research Institutions to advance cancer research

Nyheten uppdaterades 2013-07-09 8:08

AstraZeneca today announced that it has entered into an agreement with The University of Cambridge and Cancer Research UK for a two-year on three pre-clinical and clinical projects. This agreement with world-leading medical research institutions based in Cambridge, UK, aims to advance cancer research through the study of mutations and new investigational therapies in prostate,…

Källa: Mynewsdesk news release

Lämna gärna en kommentar